Caris Life Sciences (CAI) Other Non-Current Assets (2024 - 2026)

Caris Life Sciences' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $46.2 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 1029.74% year-over-year to $46.2 million; the TTM figure through Mar 2026 stood at $46.2 million (up 1029.74% YoY), while the FY2025 annual figure was $45.3 million, up 11.03% from the prior year.
• Other Non-Current Assets was $46.2 million for Q1 2026 at Caris Life Sciences, up from $45.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $47.0 million in Q3 2025 to a low of $4.1 million in Q1 2025.
• Historically, Other Non-Current Assets has averaged $37.4 million across 3 years, with a median of $43.2 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets increased 11.03% in 2025, then jumped 1029.74% in 2026.
• A 3-year view of Other Non-Current Assets shows it stood at $40.8 million in 2024, then rose by 11.03% to $45.3 million in 2025, then increased by 1.87% to $46.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $46.2 million (Q1 2026), $45.3 million (Q4 2025), and $47.0 million (Q3 2025), per Business Quant data.